Maze Therapeutics appoints Hervé Hoppenot as chairman of the board
PositiveFinancial Markets

Maze Therapeutics has announced the appointment of Hervé Hoppenot as the new chairman of the board. This move is significant as Hoppenot brings extensive experience in the biotech industry, which could help steer the company towards innovative breakthroughs in genetic medicine. His leadership is expected to enhance Maze's strategic direction and strengthen its position in the competitive landscape.
— Curated by the World Pulse Now AI Editorial System